Tuesday, April 3, 2018

BRIEF-Motif Bio Initiates NDA Rolling Submission For Iclaprim And Provides Business Update

* MOTIF BIO INITIATES NDA ROLLING SUBMISSION FOR ICLAPRIM AND PROVIDES BUSINESS UPDATE
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)